156 related articles for article (PubMed ID: 20167054)
1. The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.
Gul AE; Keser SH; Barisik NO; Kandemir NO; Cakir C; Sensu S; Karadayi N
Diagn Pathol; 2010 Feb; 5():13. PubMed ID: 20167054
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between receptor status and results of treatment in endometrial carcinoma].
Baĭnazarova AA; Iskakova ZhK
Vopr Onkol; 2006; 52(6):654-8. PubMed ID: 17338243
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
6. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
8. Distribution of estrogen and progesterone receptors isoforms in endometrial cancer.
Kreizman-Shefer H; Pricop J; Goldman S; Elmalah I; Shalev E
Diagn Pathol; 2014 Mar; 9():77. PubMed ID: 24684970
[TBL] [Abstract][Full Text] [Related]
9. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
Yu CG; Jiang XY; Li B; Gan L; Huang JF
Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
[TBL] [Abstract][Full Text] [Related]
10. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma.
Guo T; Li B; Gu C
J BUON; 2013; 18(2):465-70. PubMed ID: 23818363
[TBL] [Abstract][Full Text] [Related]
11. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
Van Gool IC; Stelloo E; Nout RA; Nijman HW; Edmondson RJ; Church DN; MacKay HJ; Leary A; Powell ME; Mileshkin L; Creutzberg CL; Smit VT; Bosse T
Mod Pathol; 2016 Feb; 29(2):174-81. PubMed ID: 26743472
[TBL] [Abstract][Full Text] [Related]
13. Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance.
Espinosa I; Serrat N; Zannoni GF; Rovira R; D'Angelo E; Prat J
Hum Pathol; 2017 Dec; 70():6-13. PubMed ID: 28601659
[TBL] [Abstract][Full Text] [Related]
14. [Mathematical evaluation of prognostic significance of clinico-morphological and immunohistochemical features of endometrioid adenocarcinoma].
Razorenova TS; Samsonova EA; Pozharisskiĭ KM; Razorenov GI
Vopr Onkol; 2007; 53(6):682-9. PubMed ID: 18416138
[TBL] [Abstract][Full Text] [Related]
15. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475
[TBL] [Abstract][Full Text] [Related]
16. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.
Lukes AS; Kohler MF; Pieper CF; Kerns BJ; Bentley R; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC; Berchuck A
Cancer; 1994 May; 73(9):2380-5. PubMed ID: 7909491
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
18. [Characteristic and clinical significance of DNA methyltransferase 3B overexpression in endometrial carcinoma].
Dong Y; Zhou M; Ba XJ; Si JW; Li WT; Wang Y; Li D; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):788-794. PubMed ID: 27752157
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
20. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.
Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O
Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
